Novo Nordisk sues Eli Lilly over ads comparing GLP-1 medications
MarketWatch· Jaimy Lee· Jul 21, 2026 · 12:18 PM
The drugmaker says Lilly isn’t including the most up-to-date clinical information about its drugs
This is a summary. Read the complete story at MarketWatch below.
Read full article at MarketWatchRelated Stories
marketsabout 6 hours ago
World Bank warns of AI concentration risks as it lifts East Asia and Pacific growth outlook to 4.5%
The World Bank now expects the region to grow 4.5% this year, but flagged that trade growth outside AI-related goods has been "weak or negative."
CNBC Markets
marketsabout 12 hours ago
The case for Nvidia’s stock to march even higher after clinching its first record high in months
Analysts highlight the stock’s cheap valuation and the chip maker’s central role in the AI ecosystem.
MarketWatch
marketsabout 12 hours ago
This new AI model could help America close a technological gap with China
Nvidia-backed Reflection AI announced Beam, a new ultra-efficient open model that boasts capabilities on par with those of Chinese ones
MarketWatch